Ignite Creation Date:
2024-05-05 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00664781
Status:
COMPLETED
Last Update Posted:
2016-05-24
First Post:
2008-04-22
Brief Title:
RucaparibCO-338Formally Called AG-014699 or PF-0136738 in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
Sponsor:
Cancer Research UK
Organization:
Cancer Research UK
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Cancer |
| brca1 Mutation Carrier |
| brca2 Mutation Carrier |
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| stage IIIA breast cancer | View |
| stage IIIB breast cancer | View |
| stage IIIC breast cancer | View |
| stage IV breast cancer | View |
| recurrent breast cancer | View |
| stage IV ovarian epithelial cancer | View |
| recurrent ovarian germ cell tumor | View |
| stage IV ovarian germ cell tumor | View |
| ovarian stromal cancer | View |
| ovarian sarcoma | View |
| BRCA1 mutation carrier | View |
| BRCA2 mutation carrier | View |
| stage IIIA ovarian epithelial cancer | View |
| stage IIIA ovarian germ cell tumor | View |
| stage IIIB ovarian epithelial cancer | View |
| stage IIIB ovarian germ cell tumor | View |
| stage IIIC ovarian epithelial cancer | View |
| stage IIIC ovarian germ cell tumor | View |
| ovarian papillary serous carcinoma | View |